SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Plexigen developed a proprietary 3-D biochip designed to significantly enhance the capacity, efficiency, accuracy and automation of gene screening.
Plexigen
Cary, NC
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.